NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM313260 Query DataSets for GSM313260
Status Public on Feb 01, 2009
Title COPD, normal B26 (COPD-study)
Sample type RNA
 
Source name B26, COPD
Organism Homo sapiens
Characteristics Sample code: B26
Cell type: histologically normal bronchial epithelial cells that were laser microdissected from frozen bronchial wall tissue
Gender: male
Age at time of surgery: 52
Smoking status: ex
Packyears: 18
Surgery due to: lung transplantation
Type of Surgery: lung-explantation
Location tumor: not applicable
TNM stage: not applicable
COPD: COPD
FEV1: 20 %
FEV1/FVC: 33 %
GOLD stage: GOLD IV
Extracted molecule total RNA
Extraction protocol LASER DISSECTION MICROSCOPY
- Frozen bronchial wall of 8μm were used for laser dissection microscopy (LDM)
- Only histologically normal bronchial epithelial cells were isolated using laser dissection microscopy
- An area of approximately 25x106 μm2 was microdissected from the section using P.A.L.M. Microlaser Technology system (P.A.L.M., Bernried, Germany).
- Laser microdissected cells were collected in lysis buffer (Macherey-Nagel)
RNA ISOLATION
Total RNA was isolated and purified from the microdissected cells with a Nucleospin RNA II kit (Macherey-Nagel). The quantity of DNA-free total RNA was measured using a Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). RNA quality was assessed by the presence and ratio of 18S and 28S rRNA bands combined with a low baseline, monitored with RNA 6000 PicoChip (Agilent, Palo Alto, CA) on the 2100 bioanalyzer (Agilent).
RNA AMPLIFICATION
For each sample, 150 ng total RNA was amplified using the MessageAmp II kit (Ambion, Austin, USA). Briefly, 150 ng total RNA was mixed with 1 l of T7 Oligo(dT) primer in a total volume of 12 l. Primer and template were denatured by incubating at 70C for 10 minutes and annealed by putting the reaction tubes on ice. The First Strand Reaction was performed by adding 8 µl Reverse Transcription Master Mix (containing 10x First Strand buffer, Ribonuclease Inhibitor, dNTP Mix and Reverse Transcriptase) and incubating at 42C for 2 hours. Second Strand cDNA Synthesis was done by adding 63 µl Nuclease-Free Water, 10 µl 10x Second Strand Buffer, 4µl dNTP Mix, 2µl DNA Polymerase and 1 µl RNase H and incubating at 16C for 2 hours. cDNA purification was done according manufacturers protocol (Ambion). In vitro transcription was initiated by addition of 2 µl aaUTP Solution (50mM), 12 µl ATP, CTP, GTP mix (25mM), 3 µl UTP Solution (50mM), 4 µl T7 10x Reaction Buffer and 4 µl T7 Enzyme Mix and incubated at 37C for 9 hours. Machery-Nagel RNA Clean up mini spin columns are used for purification of the cRNA.
Label Cy3 and Cy5
Label protocol ULS LABELING
1. Take 1- 2 μg of aRNA. Ensure that the final concentration in the labeling reaction is above 50 ng/μL. Optimal modification degrees of the labeled material are not achieved if the final concentration of aRNA in the labeling mixture is below 50 ng/μL)
2. Add 1 μL of Cy5-ULS or Cy3-ULS per 1 μg aRNA (Always keep the ratio of μg of aRNA to μL ULS 1:1 when increasing or decreasing the amount to be labeled).
3. Add 1/10 volume of 10 x Labeling solution
4. Adjust with RNase-free water to final volume and mix by pipetting
5. Label sample by incubation for 15 minutes at 85°C
6. Place samples on ice, spin down to collect contents of tube before proceeding with purification using the KREApure columns
Dye Removal using KREApure Columns (Removal of free ULS label using KREApure columns
(20800 x g is equivalent to 14,000 rpm on eppendorf 5417C)):
1. Resuspend column material by vortexing
2. Loosen cap ¼ turn and snap off the bottom closure
3. Place the column in a 2 mL collection tube
4. Pre-spin the column for 1 minute at 20800 x g
5. Discard flow through and column cap, but re-use collection tube
6. Add 300 μL ultrapure water to the column and centrifuge for 1 min at 20,800g
7. Discard collection tube and flow-through
8. Place column in a new RNase free 1.5 mL microcentrifuge tube (not provided)
9. Add ULS-labeled aRNA onto column bed
10. Centrifuge column for 1 minute at 20800 x g
11. Flow through contains the purified labeled aRNA
 
Hybridization protocol Hybridization was performed with 750 ng of each labeled target together with fragmentation- and hybridization buffer at 60C for 17 hours onto Agilent Whole Human Genome oligoarrays following manufacturer’s protocol.
Scan protocol The microarray slides were washed following the user manual instructions and scanned using the Agilent dual laser DNA microarray scanner. The microarray data were normalized using the Agilent feature extraction software v. 8.5 (Agilent Technologies, Palo Alto, CA) with regards to no background correction.
Description -
Data processing The gene expression data were log transformed and quantile normalized (Cy3 and CY5 separate). For both Cy3 and Cy5, a filter was applied that excluded 50% of the probes with the lowest expression levels and 25% of the probes with the lowest expression range. Probes that had passed only one Cy-dye filter were excluded. The average of the normalized Cy3 and Cy5 data were used for further analysis.
 
Submission date Aug 18, 2008
Last update date Oct 23, 2008
Contact name Mirjam Boelens
Organization name UMCG
Street address Hanzeplein 1
City Groningen
ZIP/Postal code 9713 GZ
Country Netherlands
 
Platform ID GPL1708
Series (1)
GSE12472 A COPD-related gene expression signature in squamous cell lung cancer

Data table header descriptions
ID_REF
VALUE average of normalized values for Cy3 and Cy5 signal intensities

Data table
ID_REF VALUE
4 7.0944
5 8.48465
12 9.295
15 6.52765
17 7.057
19 9.17735
20 7.6323
24 9.23755
25 8.6997
31 8.18175
32 6.7
34 8.7074
39 9.48365
40 8.22585
54 8.6348
58 8.2376
62 7.54115
68 7.3933
72 9.1198
73 6.63125

Total number of rows: 14447

Table truncated, full table size 186 Kbytes.




Supplementary data files not provided
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap